Biotech | August 09, 2021
Novavax and Serum Institute submits Emergency Use Authorisation of vaccine to regulatory agencies in India, Indonesia and the Philippines
Filing for WHO Emergency Use Authorisation this month
Filing for WHO Emergency Use Authorisation this month
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Board declares interim dividend of Rs 2 per equity share
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
PAT rises to Rs 195.76 crore
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Innovative solutions and a deep understanding of the market makes this a unique combination
Arch Pharma Labs has filed the application
It is designed to tackle mental health issues
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Subscribe To Our Newsletter & Stay Updated
